Inhibition of NOTCH4 Sensitizes FLT3/ITD Acute Myeloid Leukemia Cells to FLT3 Tyrosine Kinase Inhibition

被引：0
|
作者：
Zhu, Ruiqi [1 ]
Shirley, Courtney [2 ]
Chu, Haihua [3 ]
Li, Li [4 ]
Bao Nguyen [5 ]
Seo, Jaesung [2 ]
Seale, Tessa [5 ]
Duffield, Amy [6 ]
Staudt, Louis M. [7 ]
Levis, Mark J. [8 ]
Hu, Yu [1 ]
Small, Donald [5 ]
机构：
[1] Huazhong Univ Sci & Technol, Inst Hematol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China
[2] Johns Hopkins Univ, Baltimore, MD USA
[3] Beam Therapeut, Cambridge, MA USA
[4] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[5] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD USA
[6] Mt Sinai, New York, NY USA
[7] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD USA
[8] Johns Hopkins Univ, Div Hematol Malignancies, Baltimore, MD USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190696
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] FLT3 inhibition upregulates OCT4/NANOG to promote maintenance and TKI resistance of FLT3-ITD+ acute myeloid leukemia
    Qi Zhou
    Zijian Li
    Pingping Zhao
    Yongyu Guan
    Huiyuan Chu
    Yaming Xi
    Oncogenesis, 14 (1)
  • [32] Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy
    Zhang, Weiguo
    Yu, Guopan
    Zhang, Hongying
    Basyal, Mahesh
    Ly, Charlie
    Yuan, Bin
    Ruvolo, Vivian
    Piya, Sujan
    Bhattacharya, Seemana
    Zhang, Qi
    Borthakur, Gautam
    Battula, Venkata L.
    Konopleva, Marina
    Rice, William G.
    Andreeff, Michael
    HAEMATOLOGICA, 2023, 108 (06) : 1500 - 1514
  • [33] FLT3 AND FLT3-ITD GENE MUTATIONS AND PROGNOSIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Chen, L. G.
    Pei, R. Z.
    Lu, Y.
    Zhang, P. S.
    Liu, X. H.
    Du, X. H.
    Chen, D.
    Cao, J. J.
    Li, S. Y.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (06): : 1855 - 1861
  • [34] FLT3 inhibition selectively kills childhood acute lymphoblastic leukemia cells with high levels of FLT3 expression
    Brown, P
    Levis, M
    Shurtleff, S
    Campana, D
    Downing, J
    Small, D
    BLOOD, 2005, 105 (02) : 812 - 820
  • [35] Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition
    Brown, P
    Meshinchi, S
    Levis, M
    Alonzo, TA
    Gerbing, R
    Lange, B
    Arceci, R
    Small, D
    BLOOD, 2004, 104 (06) : 1841 - 1849
  • [36] Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinase
    Weisberg, Ellen L.
    Puissant, Alexandre
    Stone, Richard
    Sattler, Martin
    Buhrlage, Sara J.
    Yang, Jing
    Manley, Paul W.
    Meng, Chengcheng
    Buonopane, Michael
    Daley, John F.
    Lazo, Suzan
    Wright, Renee
    Weinstock, David M.
    Christie, Amanda L.
    Stegmaier, Kimberly
    Griffin, James D.
    ONCOTARGET, 2017, 8 (32) : 52026 - 52044
  • [37] Mutations in FLT3/ITD Produce Varying Levels of Resistance to FLT3 Tyrosine Kinase Inhibitors.
    Williams, Allen
    Nguyen, Bao
    Levis, Mark
    Brown, Patrick
    Small, Donald
    BLOOD, 2009, 114 (22) : 1452 - 1453
  • [38] Targeted inhibition of FLT3 overcomes the block to myeloid differentiation in 32Dcl3 cells caused by expression of FLT3/ITD mutations
    Zheng, R
    Friedman, AD
    Small, D
    BLOOD, 2002, 100 (12) : 4154 - 4161
  • [39] CCT137690, a dual inhibitor of Aurora and FLT3 kinases, sensitizes FLT3-ITD positive acute myeloid leukemia and overcomes resistance to selective FLT3-inhibition
    Moore, Andrew S.
    Faisal, Amir
    Bavetsias, Vassilios
    Sun, Chongbo
    Atrash, Butrus
    Valenti, Melanie
    Brandon, Alexis de Haven
    Avery, Sian
    de Castro, David Gonzalez
    Raynaud, Florence I.
    Workman, Paul
    Pearson, Andrew D. J.
    Biagg, Julian
    Eccles, Suzanne A.
    Linardopoulos, Spiros
    CANCER RESEARCH, 2011, 71
  • [40] FLT3 kinase inhibitors in the management of acute myeloid leukemia
    Illmer, Thomas
    Ehninger, Gerhard
    CLINICAL LYMPHOMA & MYELOMA, 2007, 8 : S24 - S34
12345